Growth factor-triggered de-sialylation controls glycolipid-lectin-driven endocytosis
- PMID: 39984654
- DOI: 10.1038/s41556-025-01616-x
Growth factor-triggered de-sialylation controls glycolipid-lectin-driven endocytosis
Erratum in
-
Publisher Correction: Growth factor-triggered de-sialylation controls glycolipid-lectin-driven endocytosis.Nat Cell Biol. 2025 Mar;27(3):545. doi: 10.1038/s41556-025-01643-8. Nat Cell Biol. 2025. PMID: 40000851 No abstract available.
Abstract
Glycolipid-lectin-driven endocytosis controls the formation of clathrin-independent carriers and the internalization of various cargos such as β1 integrin. Whether this process is regulated in a dynamic manner remained unexplored. Here we demonstrate that, within minutes, the epidermal growth factor triggers the galectin-driven endocytosis of cell-surface glycoproteins, such as integrins, that are key regulators of cell adhesion and migration. The onset of this process-mediated by the Na+/H+ antiporter NHE1 as well as the neuraminidases Neu1 and Neu3-requires the pH-triggered enzymatic removal of sialic acids whose presence otherwise prevents galectin binding. De-sialylated glycoproteins are then retrogradely transported to the Golgi apparatus where their glycan make-up is reset to regulate EGF-dependent invasive-cell migration. Further evidence is provided for a role of neuraminidases and galectin-3 in acidification-dependent bone resorption. Glycosylation at the cell surface thereby emerges as a dynamic and reversible regulatory post-translational modification that controls a highly adaptable trafficking pathway.
© 2025. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests: H.L. is a shareholder in Galecto Biotech AB, a company that is developing galectin inhibitors. The other authors declare no conflicts of interest.
References
-
- Avraham, R. & Yarden, Y. Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat. Rev. Mol. Cell Biol. 12, 104–117 (2011). - PubMed
-
- Takahashi, M., Hasegawa, Y., Gao, C., Kuroki, Y. & Taniguchi, N. N-glycans of growth factor receptors: their role in receptor function and disease implications. Clin. Sci. 130, 1781–1792 (2016).
MeSH terms
Substances
Grants and funding
- ANR-10-IDEX-0001-02 PSL/Agence Nationale de la Recherche (French National Research Agency)
- ANR-17-CONV-0005/Agence Nationale de la Recherche (French National Research Agency)
- ANR-19-CE13-0001-01/Agence Nationale de la Recherche (French National Research Agency)
- ANR-20-CE15-0009-01/Agence Nationale de la Recherche (French National Research Agency)
- ANR-22-CE11-0030-03/Agence Nationale de la Recherche (French National Research Agency)
- ANR-11-LABX-0043/Agence Nationale de la Recherche (French National Research Agency)
- ANR11-LABX-0038/Agence Nationale de la Recherche (French National Research Agency)
- ANR10-INBS-01/Agence Nationale de la Recherche (French National Research Agency)
- ANR-10-INBS-04-07/Agence Nationale de la Recherche (French National Research Agency)
- n°200014/Mizutani Foundation for Glycoscience (Mizutani Foundation)
- NNF0067602/Novo Nordisk Fonden (Novo Nordisk Foundation)
- DNRF107/Novo Nordisk Fonden (Novo Nordisk Foundation)
- DCRPGF\100002go/Cancer Research UK (CRUK)
- 203128/A/16/Z/Wellcome Trust (Wellcome)
- 226804/Z/22/Z/Wellcome Trust (Wellcome)
- LIP-2021-017/Leverhulme Trust
LinkOut - more resources
Full Text Sources
Miscellaneous
